STAAR Surgical Company (STAA)

Market Cap	966.93M
Revenue (ttm)	279.13M
Net Income (ttm)	-71.08M
Shares Out	49.51M
EPS (ttm)	-1.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,150,308
Open	18.50
Previous Close	19.44
Day's Range	18.50 - 20.25
52-Week Range	13.50 - 49.86
Beta	0.66
Analysts	Hold
Price Target	27.17 (+39.12%)
Earnings Date	May 7, 2025

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1982
• Employees: 1,157
• Stock Exchange: NASDAQ
• Ticker Symbol: STAA
• Website: https://www.staar.com

Analyst Forecast

According to 8 analysts, the average rating for STAA stock is "Hold." The 12-month stock price forecast is $27.17, which is an increase of 39.12% from the latest price.

Price Target

$27.17

(39.12% upside)

Analyst Consensus: Hold